Pantoprazol Lannacher (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Lannacher, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Pantoprazol Lannacher as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Lannacher as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Lannacher is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several clinical conditions where acid suppression is required. - Gastro‑esophageal reflux disease (GERD): relief of heartburn and esophageal healing. - Erosive esophagitis: promotes healing of erosive lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: used as adjunct adjunct therapy in combination regimens.

Pantoprazol Lannacher is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Clostridioides difficile‑associated colitis: persistent watery diarrhea. - Acute interstitial nephritis: renal impairment signs. - Osteoporosis‑related fractures: increased risk with long‑term use. - Vitamin B12 deficiency: may develop with prolonged therapy. - Hepatotoxicity: elevated liver enzymes or jaundice.

When prescribing Pantoprazol Lannacher, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be required in severe impairment. - Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections. - Evaluate bone health: long‑term therapy may affect calcium absorption. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed. - Store at below 25°C: keep in the original pack , protect from moisture.

Pantoprazol Lannacher    

Major  t   t   \\  \